Commercial Services Healthcare Sector

LungLife AI

Market Cap: UK£1.1m

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

InVitro International

Market Cap: US$1.4m

Develops test kits for non-animal testing applications in the United States and internationally.

CardioComm Solutions

Market Cap: CA$1.9m

Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.

Meridian Holdings

Market Cap: US$1.4m

Through its subsidiaries, provides healthcare management and information system solutions in the United States.

Halberd

Market Cap: US$1.4m

A biotech company, develops treatments for neurodegenerative diseases.

Salarius Pharmaceuticals

Market Cap: US$1.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

Processa Pharmaceuticals

Market Cap: US$1.3m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

Acura Pharmaceuticals

Market Cap: US$1.3m

An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.

Avenir Wellness Solutions

Market Cap: US$1.3m

Through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness.

Dakshidin Corporation

Market Cap: US$1.3m

Through its subsidiaries, operates as a CBD/cannabis-based medical product company.

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

Shuttle Pharmaceuticals Holdings

Market Cap: US$1.3m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

AdAlta

Market Cap: AU$1.9m

A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

Non-Invasive Monitoring Systems

Market Cap: US$1.2m

Does not have significant operations.

Target Group

Market Cap: US$1.2m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

Certive Solutions

Market Cap: CA$1.8m

Provides revenue cycle consultative services and solutions in the United States.

Standard Dental Labs

Market Cap: US$1.2m

A dental laboratory company, manufactures dental products in Florida.

Panbela Therapeutics

Market Cap: US$1.2m

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

Shortwave Life Sciences

Market Cap: UK£871.8k

Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.

Adastra Holdings

Market Cap: CA$1.6m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

Bespoke Extracts

Market Cap: US$1.1m

Bespoke Extracts, Inc., along with its subsidiary, Bespoke Extracts Colorado, LLC, specializes in the production and sale of pre-rolled marijuana cigarettes in the United States.

Silo Wellness

Market Cap: CA$1.5m

A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.

PreAxia Health Care Payment Systems

Market Cap: US$1.1m

Focuses on the development, distribution, marketing, and sale of health care payment processing services and products.

NovelStem International

Market Cap: US$1.1m

A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

GelStat

Market Cap: US$1.1m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

Captor Capital

Market Cap: CA$1.5m

Engages in the retail sale of cannabis products in the United States.

SPO Global

Market Cap: US$1.1m

Does not have significant operations.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

Modern Mobility Aids

Market Cap: US$1.1m

Operates in the telehealth and telemedicine industry.

New Leaf Ventures

Market Cap: CA$1.5m

Engages in processing, packaging, marketing, and distributing cannabis and related products.

Access-Power

Market Cap: US$1.1m

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Regen BioPharma

Market Cap: US$1.1m

Focuses on the development of regenerative medical applications in the United States.

CYduct Diagnostics

Market Cap: US$1.1m

A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.

Bluejay Diagnostics

Market Cap: US$1.1m

Operates as a medical diagnostics company.